These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32957417)

  • 21. The efficacy and safety of Chinese traditional medicine injections on patients with coronavirus disease 2019: A protocol for systematic review and meta analysis.
    Li Y; Xu H; Lang H; Li J; Bi L; Li Y; Dong L; Zhang L; Liang X; Zhu H
    Medicine (Baltimore); 2020 Jul; 99(31):e21024. PubMed ID: 32756089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
    Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.
    Li Y; Liu X; Guo L; Li J; Zhong D; Zhang Y; Clarke M; Jin R
    Syst Rev; 2020 Apr; 9(1):75. PubMed ID: 32268923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019.
    Wang X; Xie P; Sun G; Zhao M; Deng Z; Zhou Y; Bao S
    Medicine (Baltimore); 2020 Jul; 99(30):e21402. PubMed ID: 32791753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.
    Zhang J; Li S; Zhao C; Wang W; Li F; Li F
    Medicine (Baltimore); 2020 Sep; 99(38):e22277. PubMed ID: 32957380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese medicine for COVID-19: A protocol for systematic review and meta-analysis.
    Chen H; Xie Z; Zhu Y; Chen Q; Xie C
    Medicine (Baltimore); 2020 Jun; 99(25):e20660. PubMed ID: 32569196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Trials; 2020 May; 21(1):422. PubMed ID: 32448345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness and safety of antiviral agents for patients with COVID-19: Protocol for a systematic review and individual-patient data network meta-analysis.
    Cao Y; Shan J; Gong Z; Kuang J; Gao Y
    PLoS One; 2020; 15(11):e0241947. PubMed ID: 33166346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
    Ford N; Vitoria M; Rangaraj A; Norris SL; Calmy A; Doherty M
    J Int AIDS Soc; 2020 Apr; 23(4):e25489. PubMed ID: 32293807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis.
    Zhou M; Liang Q; Pei Q; Xu F; Wen H
    Medicine (Baltimore); 2020 Aug; 99(33):e21034. PubMed ID: 32871977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and meta-analysis.
    Chen H; Song YP; Gao K; Zhao LT; Ma L
    Medicine (Baltimore); 2020 Jun; 99(24):e20612. PubMed ID: 32541495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Wang Y; Xu X; Sun Y; Li J; Qi X; Sun S; Ji G; Song B
    Medicine (Baltimore); 2020 Jun; 99(24):e20531. PubMed ID: 32541475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribavirin therapy for severe COVID-19: a retrospective cohort study.
    Tong S; Su Y; Yu Y; Wu C; Chen J; Wang S; Jiang J
    Int J Antimicrob Agents; 2020 Sep; 56(3):106114. PubMed ID: 32712334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.